Journal
JOURNAL OF VETERINARY INTERNAL MEDICINE
Volume 36, Issue 2, Pages 379-396Publisher
WILEY
DOI: 10.1111/jvim.16377
Keywords
feline; fibroblast growth factor-23; kidney injury molecule-1; liver-type fatty acid-binding protein; neutrophil gelatinase-associated lipocalin; transforming growth factor-beta 1
Categories
Funding
- Mahidol University
Ask authors/readers for more resources
Serum creatinine concentration has limitations as a biomarker of early CKD in cats, and there is a need for novel biomarkers to improve early detection and intervention.
Serum creatinine concentration, the classical biomarker of chronic kidney disease (CKD) in cats, has important limitations that decrease its value as a biomarker of early CKD. Recently, serum symmetric dimethylarginine concentration was introduced as a novel glomerular filtration rate biomarker for the early detection of CKD in cats. However, data on its specificity are still limited. The limitations of conventional biomarkers and the desire for early therapeutic intervention in cats with CKD to improve outcomes have prompted the discovery and validation of novel renal biomarkers to detect glomerular or tubular dysfunction. Changes in the serum or urinary concentrations of these biomarkers may indicate early kidney damage or predict the progression of kidney before changes in conventional biomarkers are detectable. This review summarizes current knowledge on renal biomarkers in CKD in cats, a field that has progressed substantially over the last 5 years.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available